Mechanisms of Inherited Retinal Degenerative Diseases and Emerging Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 10217
Special Issue Editors
2. Department of Ophthalmology and Visual Neurosciences. University of Minnesota, Lions Research Building, 2001 6th St SE, Room 219, Minneapolis, MN 55455, USA
Special Issue Information
Dear Colleagues,
Blindness due to retinal diseases represents a huge socio-economic burden in both developed and developing nations worldwide, affecting the quality of life of an individual. Neurodegeneration, resulting from retinal neuronal cell death, has been primarily implicated in vision loss. The process of neurodegeneration is the underlying feature and a common cause of several degenerative diseases of the retina. These include glaucoma, diabetic retinopathy, age-related macular degeneration, and other forms of inherited retinal diseases. Inherited retinal degenerative diseases (RDDs) are a genetically and phenotypically heterogeneous group of visual disorders, which primarily affect the function of photoreceptor cells and are among the leading causes of clinical blindness in humans. Various biochemical pathways and genetic mechanisms are affected in the retina and photoreceptor cells of patients with retinal degenerative diseases. These include key genes and enzymes in the phototransduction pathway, protein trafficking, connecting cilium, lipid metabolism, retinal development, and synaptic function. Besides photoreceptor injury/death and retinal neurodegeneration, breakdown of the blood–retinal barrier, retinal pigmented epithelium (RPE) dysfunction and mitochondrial dysregulation also have a plausible critical role in retinal pathologies. Although much progress has been made when it comes to understanding the cause and impact of photoreceptors and RPE in various pathological conditions involving the retina, the precise mechanisms leading to neurodegeneration and death of retinal neurons are far from being fully elucidated. Likewise, the underlying mechanisms of neuroprotection are also still obscure. With the advent of next-generation sequencing, tremendous progress has been made in discovering genes and genetic defects that cause inherited RDDs. The major challenge now is to functionally characterize these gene products to delineate the biological mechanisms of retinal disease pathogenesis using in vitro and in vivo models, with the goal of designing gene-based treatments. Although much effort is directed towards identifying the genetic components of retinal disease, little is known about the role of epigenetic mechanisms in the development of complex and multifactorial retinal diseases. Epigenetic changes (e.g., methylation, histone modifications, microRNA dysregulation) via the regulation of gene expression may play a crucial role in the development and/or progression of common retinal diseases and warrant systematic investigations. While advances have been made in elucidating the pathophysiological mechanisms underlying the genetic causes of retinal dystrophies, therapeutic approaches are now being explored to mitigate vision loss in such patients. It is crucial to establish animal models to elucidate retinal and photoreceptor biology in retinal diseases and in the development of novel gene-based and cell-based therapeutic modalities. There is an evolving interest in developing nutrient-based neuroprotective therapy in retinal diseases. Newer and improved therapeutic approaches will greatly enhance the quality of life of individuals living with these potentially blinding diseases and facilitate effective disease management.
Research topics of interest for this Special Issue include, but are not limited to:
- Novel mechanisms regulating protein trafficking to the photoreceptor outer segments
- Mistrafficking of phototransduction proteins in retinal cell death
- Mechanisms in age-related macular degeneration
- Mechanisms of secondary cone photoreceptor cell death
- Exosomes in retinal degenerative diseases
- Genetic and epigenetic mechanisms in retinal degenerative diseases
- Mitochondrial dysregulation in retinal degenerative diseases
- Nutrient based therapy in retinal degenerative diseases
- Adeno-associated viral gene therapy for retinal degenerative diseases
- Mechanisms influencing transport and delivery of vitamin A and carotenoids to the eye
- Genomics, proteomics, and metabolomics of age-related macular degeneration
- Attenuation of inherited retinal degeneration progression with gene-based technology
Dr. Glenn Lobo
Dr. Altaf A. Kondkar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.